anti-CD20anti-CD3 bispecific antibody MBS303 - National

mbs303MBS303 is a CD20×CD3 T-cell-engaging bispecific antibody that has a novel 2:1 (CD20:CD3) confuration to kill malnant B cells. This dose-escalation phase Ⅰ trial evaluated the safetyMBS303 * Melestarikan Hutan Indonesia untuk Masa Depan yang Lebih Hijau. IDR 10,000.00. MBS303 menekankan pentingnya menggunakan media sosial secara positif.